Claim this
Startup
Write to the
Adimab

Adimab

http://www.adimab.com
Biotechnology

About Adimab

Adimab’s yeast-based discovery platform functions as a synthetic human immune system to create novel antibody therapeutics across an extensive range of diseases, including cancer as well as autoimmu...

Adimab describes itself with 2 words or categories

BiotechnologyHuman antibody discovery

Video

Presentation

Case Study

Competitive Landscape

Capitalization

Adimab appears to have raised $45,282,384.

  • #DATA_YEAR# : $
    #NAME#
    from #DATA_FROM#
  • Location

    Headquarters

    7 Lucent Drive
    Lebanon, New Hampshire , 03766
    United States

    Company Size

    51-200 employees

    Type

    Privately Held

    Founded

    2007